ACLARIS THERAPEUTICS INC (ACRS) Stock Income Statement
NASDAQ:ACRS - Nasdaq - US00461U1051 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.78M | 18.72M | 31.25M | 29.75M | 6.76M | |||
| Cost Of Goods | 15.13M | 15.46M | 18.08M | 11.96M | 4.71M | |||
| Gross Profit | 2.64M | 3.26M | 13.17M | 17.79M | 2.05M | |||
| Operating Expenses | 56.82M | 58.29M | 102.58M | 102.95M | 67.43M | |||
| Research and Development | 35.33M | 33.59M | 98.38M | 77.81M | 43.81M | |||
| Selling, General, and Administrative Expenses | 21.50M | 22.20M | 31.10M | 25.13M | 23.62M | |||
| Operating Income | -54.18M | -55.03M | -89.41M | -85.15M | -65.38M | |||
| Interest Income/Expense | N/A | 7.95M | N/A | N/A | N/A | |||
| Other Income/Expense | 4.62M | 1.91M | 8.51M | 2.95M | -1.14M | |||
| Non Recurring Items | N/A | -86.91M | -7.94M | -4.70M | -24.34M | |||
| Income Before Taxes | -130.21M | -132.06M | -88.85M | -86.91M | -90.87M | |||
| Income Tax | N/A | 0.00 | -367.00K | 0.00 | 0.00 | |||
| Net Income | -130.21M | -132.06M | -88.48M | -86.91M | -90.87M | |||
| EBITDA | -53.49M | -54.22M | -88.55M | -84.35M | -64.46M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.40 | -1.71 | -1.27 | -1.33 | -1.60 | |||
| Non GAAP EPS | -1.39 | -1.51 | -1.25 | -1.33 | -1.63 | |||
| Statistics | ||||||||
| Gross Profit Margin | 14.87% | 17.43% | 42.14% | 59.80% | 30.33% | |||
| Profit Margin | -732.42% | -705.48% | -283.15% | -292.13% | -1344.23% | |||
| Operating Profit Margin | -304.75% | -293.95% | -286.13% | -286.22% | -967.16% | |||
All data in USD